Adjuvant effects of salidroside from Rhodiola rosea L. on the immune responses to ovalbumin in mice

Immunopharmacology and Immunotoxicology

Volumn 33, Issue 4, 2011, Pages 738-743

  Guan, Shuang ^a   He, Jiakang ^b   Guo, Weixiao ^a   Wei, Jingyuan ^a   Lu, Jing ^a   Deng, Xuming ^a  

^a JILIN UNIVERSITY   (China)

^b GUANGXI UNIVERSITY   (China)

Author keywords

Adjuvant; Antibody; Cytokines; Salidroside

Indexed keywords

GAMMA INTERFERON; IMMUNOGLOBULIN G; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G2B; INTERLEUKIN 2; INTERLEUKIN 4; OVALBUMIN; SALIDROSIDE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD SAMPLING; CD8+ T LYMPHOCYTE; CELL PROLIFERATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG EFFECT; IMMUNE RESPONSE; LYMPHOCYTE; MALE; MEDICINAL PLANT; NONHUMAN; PRIORITY JOURNAL; RHODIOLA ROSEA; SPLEEN CELL; TREATMENT DURATION;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CELL PROLIFERATION; CYTOKINES; GLUCOSIDES; IMMUNITY, CELLULAR; IMMUNITY, HUMORAL; IMMUNIZATION; IMMUNOGLOBULIN G; MALE; MICE; MICE, INBRED BALB C; OVALBUMIN; PHENOLS; RHODIOLA;

MUS; RHODIOLA ROSEA;

EID: 80755143818     PISSN: 08923973     EISSN: 15322513     Source Type: Journal    
DOI: 10.3109/08923973.2011.567988     Document Type: Article

References (30)

1. Medzhitov, R., Janeway, C.A., Jr. Innate immunity: the virtues of a nonclonal system of recognition. Cell 1997, 91, 295-298. (Pubitemid 27467959)
2. Song, X., Hu, S. Adjuvant activities of saponins from traditional Chinese medicinal herbs. Vaccine 2009, 36, 4883-4890.
3. Song, Q.H., Kobayashi, T., Xiu, L.M., Tie, H., Cyong, J.C. Effects of Astragali root and Hedysari root on the murine B and T cell differentiation. J Ethnopharmacol 2000, 73, 111-119.
4. Fischer, G., Concei?o, F.R., Leite, F.P., Dummer, L.A., Vargas, G.D., Huner Sde, O., Dellagostin, O.A., Paulino, N., Paulino, A.S., Vidor, T. Immunomodulation produced by a green propolis extract on humoral and cellular responses of mice immunized with SuHV-1. Vaccine 2007, 25, 1250-1256. (Pubitemid 46039846)
5. Rivera, E., Ekholm Pettersson, F., Ingan?, M., Paulie, S., Grońvik, K.O. The Rb1 fraction of ginseng elicits a balanced Th1 and Th2 immune response. Vaccine 2005, 23, 5411-5419. (Pubitemid 41579313)
6. Yesilada, E., Bedir, E., Calis, I., Takaishi, Y., Ohmoto, Y. Effects of triterpene saponins from Astragalus species on in vitro cytokine release. J Ethnopharmacol 2005, 96, 71-77. (Pubitemid 39575033)
7. Yoshida, Y., Wang, M.Q., Liu, J.N., Shan, B.E., Yamashita, U. Immunomodulating activity of Chinese medicinal herbs and Oldenlandia diffusa in particular. Int J Immunopharmacol 1997, 7, 359-370. (Pubitemid 28137502)
8. Ragupathi, G., Damani, P., Deng, K., Adams, M.M., Hang, J., George, C., Livingston, P.O., Gin, D.Y. Preclinical evaluation of the synthetic adjuvant SQS-21 and its constituent isomeric saponins. Vaccine 2010, 26, 4260-4267.
9. Sun, H.X., Qin, F., Ye, Y.P. Relationship between haemolytic and adjuvant activity and structure of protopanaxadiol-type saponins from the roots of Panax notoginseng. Vaccine 2005, 12, 5533-5542. (Pubitemid 41608602)
10. Kelly, G.S. Rhodiola rosea: a possible plant adaptogen. J Altern Med Rev 2001, 6, 293-302. (Pubitemid 32591865)
11. Huang, S.C., Lee, F.T., Kuo, T.Y., Yang, J.H., Chien, C.T. Attenuation of long-term Rhodiola rosea supplementation on exhaustive swimming-evoked oxidative stress in the rat. J Chin J Physiol 2009, 52, 316-324.
12. Iaremii, I.N., Grigor'eva, N.F. [Hepatoprotective properties of liquid extract of Rhodiola rosea]. Eksp Klin Farmakol 2002, 65, 57-59.
13. Ming, D.S., Hillhouse, B.J., Guns, E.S., Eberding, A., Xie, S., Vimalanathan, S., Towers, G.H. Bioactive compounds from Rhodiola rosea (Crassulaceae). Phytother Res 2005, 19, 740-743. (Pubitemid 41571421)
14. Mattioli, L., Perfumi, M. Rhodiola rosea L. extract reduces stressand CRF-induced anorexia in rats. J Psychopharmacol (Oxford) 2007, 21, 742-750. (Pubitemid 47437914)
15. Perfumi, M., Mattioli, L. Adaptogenic and central nervous system effects of single doses of 3% rosavin and 1% salidroside Rhodiola rosea L. extract in mice. Phytother Res 2007, 21, 37-43. (Pubitemid 46173906)
16. Li, H.B., Chen, F. Preparative isolation and purification of salidroside from the Chinese medicinal plant Rhodiola sachalinensis by highspeed counter-current chromatography. J Chromatogr A 2001, 932, 91-95. (Pubitemid 32938190)
17. Wang, J.M., Shan, J.P., Wang, S.Q. Progress of research study on pharmacological action of Rhodiola rosea. J ACMP 2003, 31, 57-59.
18. Kucinskaite, A., Briedis, V., Savickas, A. [Experimental analysis of therapeutic properties of Rhodiola rosea L. and its possible application in medicine]. Medicina (Kaunas) 2004, 40, 614-619.
19. Wang, H., Ding, Y. The in vitro and in vivo antiviral effects of salidroside from Rhodiola rosea L. against coxsackievirus B3. J Phytomed 2009, 16, 146-155.
20. Wu, Y.L., Lian, L.H., Jiang, Y.Z., Nan, J.X. Hepatoprotective effects of salidroside on fulminant hepatic failure induced by d-galactosamine and lipopolysaccharide in mice. J Pharm Pharmacol 2009, 61, 1375-1382.
21. Yin, D.K., Yao, W., Chen, S., Hu, R., Gao, X. Salidroside, the main active compound of Rhodiola plants, inhibits high glucose-induced mesangial cell proliferation. Planta Med 2009, 75, 1191-1195.
22. Mao, G.X., Deng, H.B., Yuan, L.G., Li, D.D., Li, Y.Y., Wang, Z. Protective effect against aging in a mouse model induced by D-galactose. Biomed Environ Sci 2010, 23, 161-166.
23. Zhong, H., Xin, H., Wu, L.X., Zhu, Y.Z. Salidroside attenuates apoptosis in ischemic cardiomyocytes: a mechanism through a mitochondria-dependent pathway. J Pharmacol Sci 2010, 4, 399-408.
24. Byun, J.A., Ryu, M.H., Lee, J.K. The immunomodulatory effects of 3-monochloro-1,2-propanediol on murine splenocyte and peritoneal macrophage function in vitro. Toxicol In Vitro 2006, 20, 272-278. (Pubitemid 43343756)
25. Caballero-Hern?dez, D., Weberb, R.J, Hicks, M.E., Tamez-Guerra, R., Rodr?uez-Padilla, C., Tamez-Guerra, P., Rice, K.C., Ananthan, S., Gomez-Flores, R. Potentiation of rat lymphocyte proliferation by novel non-peptidic synthetic opioids. J Int Immunopharmacol 2005, 5, 1271-1278. (Pubitemid 40725720)
26. + T-lymphocytes after strontium-89 chloride therapy for painful bone metastases in patients correlate with treatment efficacy. Cancer Biother Radiopharm 2000, 6, 362-367.
27. Lee, J.K., Ryu, M.H., Byun, J.A. Immunotoxic effect of betachlorolactic acid on murine splenocyte and peritoneal macrophage function in vitro. Toxicology 2005, 210, 175-187. (Pubitemid 40517161)
28. Sun, H.X., Qin, F., Ye, Y.P. Relationship between haemolytic and adjuvant activity and structure of protopanaxadiol-type saponins from the roots of Panax notoginseng. Vaccine 2005, 23, 5533-5542. (Pubitemid 41608602)
29. O'Hagan, D.T., MacKichan, M.L., Singh, M. Recent developments in adjuvants for vaccines against infectious diseases. Biomol Eng 2001, 18, 69-85. (Pubitemid 32889607)
30. O'Haagan, D.T., MacKichan, M.L., Singh, M. Recent developments in adjuvants for vaccines against infectious diseases. Biomol Eng 2001, 18, 69-85. (Pubitemid 32889607)